444731-75-3Relevant articles and documents
Preparation method of pazopanib intermediate
-
, (2021/03/24)
The invention provides a preparation method of a pazopanib key intermediate 2,3-dimethyl-N-(2-chloropyrimidin-4-yl)-N-methyl-2H-indazole-6-amine. The method comprises the following steps: by taking 6-halogenated-2,3-dimethyl-2H-indazole as a raw material, conducting reacting to obtain N,2,3-trimethyl-2H-indazole-6-amine; and further carrying out a reaction to obtain the 2,3-dimethyl-N-(2-chloropyrimidin-4-yl)-N-methyl-2H-indazole-6-amine. The method has the advantages of short synthesis route, accessible raw materials, low cost, mild reaction conditions, high safety and high yield, and is suitable for industrial mass production.
Green preparation method of palatinib hydrochloride (by machine translation)
-
Paragraph 0086-0094, (2019/08/01)
The invention belongs to the technical field of chemical synthesis of medicines, and belongs to the technical field of pharmaceutical chemistry. The invention particularly relates to a green preparation method. The o-methyl aniline and N - chlorosuccinimide are chlorinated to obtain 2 - methyl -5 - chloro- aniline; the 6 - chlorine - 222H-indole hydrochloride is obtained by reacting with the nitrous acid compound; N-methyl -6 -chloro - 222H-indole; under the participation of dimethyl sulfoxide, 3 - 2-dimethyl 3 - chlorine -6 - 222H-indazole; and the like. A reaction with 2 - chloro -4 - amino - pyrimidine and iodomethane gave N - (2 -chloropyrimidine -4 -yl) - N N-methyl -2, 3 -dimethyl - 222H-indazole -6 - amine; and finally, a pimatinib hydrochloride salt was obtained by reaction with 3 - sulfanilide -4 - methyl - aniline. The method is low in raw material price, simple to operate, low in operation risk, capable of avoiding waste acid generation, high in reaction yield, and high in purity. (by machine translation)
Pazopanib structure based HDAC (histone deacetylase) and VEGFR (vascular endothelial growth factor receptor) dual-target inhibitor and preparation method and application thereof
-
, (2018/03/28)
The invention relates to a pazopanib structure based HDAC (histone deacetylase) and VEGFR (vascular endothelial growth factor receptor) dual-target inhibitor and a preparation method and application thereof. The compound has structures as are shown in formula I, formula II or formula III. The invention further provides a preparation method of the compounds and application of the compounds in preparing drugs for prevention or treatment of cancer-related diseases.